A major role for cardiovascular burden in age-related cognitive decline

Nature Reviews Cardiology

Volumn 12, Issue 5, 2015, Pages 267-277

  Qiu, Chengxuan ^a   Fratiglioni, Laura ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AGE; ARTERIAL STIFFNESS; BRAIN ATHEROSCLEROSIS; BRAIN HYPOXIA; CARDIOVASCULAR DISEASE; CARDIOVASCULAR PROCEDURE; CARDIOVASCULAR RISK; CAROTID ATHEROSCLEROSIS; CEREBRAL HYPOPERFUSION; CEREBROVASCULAR DISEASE; COGNITIVE DEFECT; DEMENTIA; HEART FAILURE; HUMAN; ISCHEMIC HEART DISEASE; META ANALYSIS (TOPIC); NERVE DEGENERATION; PATHOPHYSIOLOGY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; PUBLIC HEALTH; REVIEW; SYSTEMATIC REVIEW (TOPIC); VASCULAR RISK FACTOR; AGING; COGNITION DISORDERS; COMPLICATION; RISK FACTOR;

AGE FACTORS; AGING; CARDIOVASCULAR DISEASES; COGNITION DISORDERS; HUMANS; RISK FACTORS;

EID: 84928583748     PISSN: 17595002     EISSN: 17595010     Source Type: Journal    
DOI: 10.1038/nrcardio.2014.223     Document Type: Review

References (172)

1. Qiu, C., Kivipelto, M. & von Strauss, E. Epidemiology of Alzheimer's disease: occurrence, determinants, and strategies toward intervention. Dialogues Clin. Neurosci. 11, 111-128 (2009).
2. Reitz, C., Brayne, C. & Mayeux, R. Epidemiology of Alzheimer disease. Nat. Rev. Neurol. 7, 137-152 (2011).
3. Schneider, J. A., Arvanitakis, Z., Bang, W. & Bennett, D. A. Mixed brain pathologies account for most dementia cases in community-dwelling older persons. Neurology 69, 2197-2204 (2007).
4. Schneider, J. A., Arvanitakis, Z., Leurgans, S. E. & Bennett, D. A. The neuropathology of probable Alzheimer disease and mild cognitive impairment. Ann. Neurol. 66, 200-208 (2009).
5. Matthews, F. E. et al. Epidemiological pathology of dementia: attributable-risks at death in the Medical Research Council Cognitive Function and Ageing Study. PLoS Med. 6, e1000180 (2009).
6. Yang, Z., Slavin, M. J. & Sachdev, P. S. Dementia in the oldest old. Nat. Rev. Neurol. 9, 382-393 (2013).
7. Gorelick, P. B. et al. Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 42, 2672-2713 (2011).
8. Qiu, C. Preventing Alzheimer's disease by targeting vascular risk factors: hope and gap. J. Alzheimers Dis. 32, 721-731 (2012).
9. Román, G. C., Nash, D. T. & Fillit, H. Translating current knowledge into dementia prevention. Alzheimer Dis. Assoc. Disord. 26, 295-299 (2012).
10. Nyberg, L., Lövdén, M., Riklund, K., Lindenberger, U. & Bäckman, L. Memory aging and brain maintenance. Trends Cogn. Sci. 16, 292-305 (2012).
11. Wolf, P. A. Contributions of the Framingham Heart Study to stroke and dementia epidemiologic research at 60 years. Arch. Neurol. 69, 567-571 (2012).
12. Gelber, R. P., Launer, L. J. & White, L. R. The Honolulu-Asia Aging Study: epidemiologic and neuropathologic research on cognitive impairment. Curr. Alzheimer Res. 9, 664-672 (2012).
13. Hofman, A. et al. The Rotterdam Study: 2014 objectives and design update. Eur. J. Epidemiol. 28, 889-926 (2013).
14. Chaves, P. H., Kuller, L. H., O'Leary, D. H., Manolio, T. A. & Newman, A. B. Subclinical cardiovascular disease in older adults: insights from the Cardiovascular Health Study. Am. J. Geriatr. Cardiol. 13, 137-151 (2004).
15. Fratiglioni, L., Winblad, B. & von Strauss, E. Prevention of Alzheimer's disease and dementia. Major findings from the Kungsholmen Project. Physiol. Behav. 92, 98-104 (2007).
16. Anstey, K. J., Lipnicki, D. M. & Low, L. F. Cholesterol as a risk factor for dementia and cognitive decline: a systematic review of prospective studies with meta-analysis. Am. J. Geriatr. Psychiatry 16, 343-354 (2008).
17. Peters, R. et al. Smoking, dementia and cognitive decline in the elderly, a systematic review. BMC Geriatr. 8, 36 (2008).
18. Lu, F. P., Lin, K. P. & Kuo, H. K. Diabetes and the risk of multi-system aging phenotypes: a systematic review and meta-analysis. PLoS ONE 4, e4144 (2009).
19. Beydoun, M. A. et al. Epidemiologic studies of modifiable factors associated with cognition and dementia: systematic review and meta-analysis. BMC Public Health 14, 643 (2014).
20. Qiu, C., Winblad, B. & Fratiglioni, L. The age-dependent relation of blood pressure to cognitive function and dementia. Lancet Neurol. 4, 487-499 (2005).
21. Anstey, K. J., Cherbuin, N., Budge, M. & Young, J. Body mass index in mid-life and late-life as a risk factor for dementia: a meta-analysis of prospective studies. Obes. Rev. 12, e426-e437 (2011).
22. Novak, V. & Hajjar, I. The relationship between blood pressure and cognitive function. Nat. Rev. Cardiol. 7, 686-698 (2010).
23. Tolppanen, A. M., Solomon, A., Soininen, H. & Kivipelto, M. Midlife vascular risk factors and Alzheimer's disease: evidence from epidemiological studies. J. Alzheimers Dis. 32, 531-540 (2012).
24. Whitmer, R. A., Sidney, S., Selby, J., Johnston, S. C. & Yaffe, K. Midlife cardiovascular risk factors and risk of dementia in late life. Neurology 64, 277-281 (2005).
25. Qiu, C., Xu, W., Winblad, B. & Fratiglioni, L. Vascular risk profiles for dementia and Alzheimer's disease in very old people: a population-based longitudinal study. J. Alzheimers Dis. 20, 293-300 (2010).
26. Lobo, E. et al. Is there an association between low-to-moderate alcohol consumption and risk of cognitive decline? Am. J. Epidemiol. 172, 708-716 (2010).
27. Sabia, S. et al. Alcohol consumption and cognitive decline in early old age. Neurology 82, 332-339 (2014).
28. Nooyens, A. C., Bueno-de-Mesquita, H. B., van Gelder, B. M., van Boxtel, M. P. & Verschuren, W. M. Consumption of alcoholic beverages and cognitive decline at middle age: the Doetinchem Cohort Study. Br. J. Nutr. 111, 715-723 (2014).
29. Peters, R., Peters, J., Warner, J., Beckett, N. & Bulpitt, C. Alcohol, dementia and cognitive decline in the elderly: a systematic review. Age Ageing 37, 505-512 (2008).
30. Anstey, K. J., Mack, H. A. & Cherbuin, N. Alcohol consumption as a risk factor for dementia and cognitive decline: meta-analysis of prospective studies. Am. J. Geriatr. Psychiatry 17, 542-555 (2009).
31. Singh, B. et al. Association of Mediterranean diet with mild cognitive impairment and Alzheimer's disease: a systematic review and meta-analysis. J. Alzheimers Dis. 39, 271-282 (2014).
32. Qiu, C. Epidemiological findings of vascular risk factors in Alzheimer's disease: implications for therapeutic and preventive intervention. Expert Rev. Neurother. 11, 1593-1607 (2011).
33. Shumaker, S. A. et al. Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study. JAMA 291, 2947-2958 (2004).
34. Llewellyn, D. J. et al. Framingham Stroke Risk Profile and poor cognitive function: a population-based study. BMC Neurol. 8, 12 (2008).
35. Kaffashian, S. et al. Predictive utility of the Framingham general cardiovascular disease risk profile for cognitive function: evidence from the Whitehall II study. Eur. Heart J. 32, 2326-2332 (2011).
36. Kaffashian, S. et al. Predicting cognitive decline: a dementia risk score vs. the Framingham vascular risk scores. Neurology 80, 1300-1306 (2013).
37. Kaffashian, S. et al. Midlife stroke risk and cognitive decline: a 10-year follow-up of the Whitehall II cohort study. Alzheimers Dement. 9, 572-579 (2013).
38. Dregan, A., Stewart, R. & Gulliford, M. C. Cardiovascular risk factors and cognitive decline in adults aged 50 and over: a population-based cohort study. Age Ageing 42, 338-345 (2013).
39. Yaffe, K. et al. Early adult to mid-life cardiovascular risk factors and cognitive function. Circulation 129, 1560-1567 (2014).
40. Anstey, K. J., Sargent-Cox, K., Garde, E., Cherbuin, N. & Butterworth, P. Cognitive development over 8 years in mid-life and its association with cardiovascular risk factors. Neuropsychology 28, 653-665 (2014).
41. Unverzagt, F. W. et al. Vascular risk factors and cognitive impairment in a stroke-free cohort. Neurology 77, 1729-1736 (2011).
42. Joosten, H. et al. Cardiovascular risk profile and cognitive function in young, middle-aged, and elderly subjects. Stroke 44, 1543-1549 (2013).
43. Virta, J. J. et al. Midlife cardiovascular risk factors and late cognitive impairment. Eur. J. Epidemiol. 28, 405-416 (2013).
44. Laughlin, G. A. et al. Sex differences in the association of Framingham Cardiac Risk Score with cognitive decline in community-dwelling elders without clinical heart disease. Psychosom. Med. 73, 683-689 (2011).
45. Warsch, J. R. et al. Association between northern Manhattan study global vascular risk score and successful aging. J. Am. Geriatr. Soc. 61, 519-524 (2013).
46. Zeki Al Hazzouri, A. et al. Cardiovascular risk score, cognitive decline, and dementia in older Mexican Americans: the role of sex and education. J. Am. Heart Assoc. 2, e004978 (2013).
47. Crichton, G. E., Elias, M. F., Davey, A. & Alkerwi, A. Cardiovascular health and cognitive function: the Maine-Syracuse Longitudinal Study. PLoS ONE 9, e89317 (2014).
48. Thacker, E. L. et al. The American Heart Association Life's Simple 7 and incident cognitive impairment: The REasons for Geographic And Racial Differences in Stroke (REGARDS) Study. J. Am. Heart Assoc. 3, e000635 (2014).
49. Barnes, D. E. & Yaffe, K. The projected effect of risk factor reduction on Alzheimer's disease prevalence. Lancet Neurol. 10, 819-828 (2011).
50. Karmali, K. N. & Lloyd-Jones, D. M. Adding a life-course perspective to cardiovascular-risk communication. Nat. Rev. Cardiol. 10, 111-115 (2013).
51. Barnes, D. E. et al. Predicting risk of dementia in older adults: the late-life dementia risk index. Neurology 73, 173-179 (2009).
52. Reitz, C. et al. A summary risk score for the prediction of Alzheimer disease in elderly persons. Arch. Neurol. 67, 835-841 (2010).
53. Exalto, L. G. et al. Risk score for prediction of 10 year dementia risk in individuals with type 2 diabetes: a cohort study. Lancet Diabetes Endocrinol. 1, 183-190 (2013).
54. Anstey, K. J. et al. A self-report risk index to predict occurrence of dementia in three independent cohorts of older adults: the ANU-ADRI. PLoS ONE 9, e86141 (2014).
55. Kivipelto, M. et al. Risk score for the prediction of dementia risk in 20 years among middle aged people: a longitudinal, population-based study. Lancet Neurol. 5, 735-741 (2006).
56. Exalto, L. G. et al. Midlife risk score for the prediction of dementia four decades later. Alzheimers Dement. 10, 562-570 (2014).
57. Kivipelto, M. et al. The Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability (FINGER): study design and progress. Alzheimers Dement. 9, 657-665 (2013).
58. Bursi, F. et al. Heart disease and dementia: a population-based study. Am. J. Epidemiol. 163, 135-141 (2006).
59. Rusanen, M. et al. Heart diseases and long-term risk of dementia and Alzheimer's disease: a population-based CAIDE study. J. Alzheimers Dis. 42, 183-191 (2014).
60. Newman, A. B. et al. Dementia and Alzheimer's disease incidence in relationship to cardiovascular disease in the Cardiovascular Health Study cohort. J. Am. Geriatr. Soc. 53, 1101-1107 (2005).
61. Rosano, C. & Newman, A. B. Cardiovascular disease and risk of Alzheimer's disease. Neurol. Res. 28, 612-620 (2006).
62. Haring, B. et al. Cardiovascular disease and cognitive decline in postmenopausal women: results from the Women's Health Initiative Memory Study. J. Am. Heart. Assoc. 2, e000369 (2013).
63. Eriksson, U. K., Bennet, A. M., Gatz, M., Dickman, P. W. & Pedersen, N. L. Nonstroke cardiovascular disease and risk of Alzheimer disease and dementia. Alzheimer Dis. Assoc. Disord. 24, 213-219 (2010).
64. Ikram, M. A. et al. Unrecognized myocardial infarction in relation to risk of dementia and cerebral small vessel disease. Stroke 39, 1421-1426 (2008).
65. Singh-Manoux, A. et al. History of coronary heart disease and cognitive performance in mid-life: the Whitehall II study. Eur. Heart J. 29, 2100-2107 (2008).
66. Roberts, R. O. et al. Coronary heart disease is associated with non-amnestic mild cognitive impairment. Neurobiol. Aging 31, 1894-1902 (2010).
67. Roberts, R. O. et al. Cardiac disease associated with increased risk of nonamnestic cognitive impairment: stronger effect on women. JAMA Neurol. 70, 374-382 (2013).
68. Eggermont, L. H. et al. Cardiac disease and cognitive impairment: a systematic review. Heart 98, 1334-1340 (2012).
69. Rostamian, S. et al. Cognitive impairment and risk of stroke: a systematic review and meta-analysis of prospective cohort studies. Stroke 45, 1342-1348 (2014).
70. Tolppanen, A. M. et al. Incident ischaemic heart disease in persons with Alzheimer's disease in a Finnish nationwide exposure-matched cohort. Int. J. Cardiol. 170, 195-201 (2013).
71. Singh-Manoux, A. et al. Cognition and incident coronary heart disease in late mid-life: the Whitehall II study. Intelligence 37, 529-534 (2009).
72. Nordström, P., Religa, D., Wimo, A., Winblad, B. & Eriksdotter, M. The use of cholinesterase inhibitors and the risk of myocardial infarction and death: a nationwide cohort study in subjects with Alzheimer's disease. Eur. Heart J. 34, 2585-2591 (2013).
73. ONTARGET Investigators, et al. Telmisartan, ramipril, or both in patients at high risk for vascular events. N. Engl. J. Med. 358, 1547-1559 (2008).
74. Telmisartan Randomised AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease (TRANSCEND) Investigators et al. Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomized controlled trial. Lancet 372, 1174-1183 (2008).
75. O'Donnell, M. et al. Cognitive impairment and risk of cardiovascular events and mortality. Eur. Heart J. 33, 1777-1786 (2012).
76. Kwok, C. S., Loke, Y. K., Hale, R., Potter, J. F. & Myint, P. K. Atrial fibrillation and incidence of dementia: a systematic review and meta-analysis. Neurology 76, 914-922 (2011).
77. Santangeli, P. et al. Atrial fibrillation and the risk of incident dementia: a meta-analysis. Heart Rhythm. 9, 1761-1768 (2012).
78. Kalantarian, S., Stern, T. A., Mansour, M. & Ruskin, J. N. Cognitive impairment associated with atrial fibrillation: a meta-analysis. Ann. Intern. Med. 158, 338-346 (2013).
79. Udompanich, S., Lip, G. Y., Apostolakis, S. & Lane, D. A. Atrial fibrillation as a risk factor for cognitive impairment: a semi-systematic review. QJM 106, 795-802 (2013).
80. Stefansdottir, H. et al. Atrial fibrillation is associated with reduced brain volume and cognitive function independent of cerebral infarcts. Stroke 44, 1020-1025 (2013).
81. Thacker, E. L. et al. Atrial fibrillation and cognitive decline: a longitudinal cohort study. Neurology 81, 119-125 (2013).
82. Marzona, I. et al. Increased risk of cognitive and functional decline in patients with atrial fibrillation: results of the ONTARGET and TRANSCEND studies. CMAJ 184, E329-E336 (2012).
83. Gure, T. R. et al. Prevalence of cognitive impairment in older adults with heart failure. J. Am. Geriatr. Soc. 60, 1724-1729 (2012).
84. Hajduk, A. M. et al. Cognitive change in heart failure: a systematic review. Circ. Cardiovasc. Qual. Outcomes 6, 451-460 (2013).
85. Heckman, G. A. et al. Heart failure and cognitive impairment: challenges and opportunities. Clin. Interv. Aging. 2, 209-218 (2007).
86. Ganguli, M., Fu, B., Snitz, B. E., Hughes, T. F. & Chang, C. C. Mild cognitive impairment: incidence and vascular risk factors in a population-based cohort. Neurology 80, 2112-2120 (2013).
87. Vogels, R. L., Scheltens, P., Schroeder-Tanka, J. M. & Weinstein, H. C. Cognitive impairment in heart failure: a systematic review of the literature. Eur. J. Heart Fail. 9, 440-449 (2007).
88. Pressler, S. J. Cognitive functioning and chronic heart failure: a review of the literature (2002-July 2007). J. Cardiovasc. Nurs. 23, 239-249 (2008).
89. Jefferson, A. L. et al. Cardiac index is associated with brain aging: the Framingham Heart Study. Circulation 122, 690-697 (2010).
90. Jefferson, A. L. et al. Relation of left ventricular ejection fraction to cognitive aging (from the Framingham Heart Study). Am. J. Cardiol. 108, 1346-1351 (2011).
91. Viles-Gonzalez, J. F., Fuster, V. & Badimon, J. J. Atherothrombosis: a widespread disease with unpredictable and life-threatening consequences. Eur. Heart J. 25, 1197-1207 (2004).
92. van Oijen, M. et al. Atherosclerosis and risk for dementia. Ann. Neurol. 61, 403-410 (2007).
93. Laurin, D., Masaki, K. H., White, L. R. & Launer, L. J. Ankle-to-brachial index and dementia: the Honolulu-Asia Aging Study. Circulation 116, 2269-2274 (2007).
94. Guerchet, M. et al. Ankle-brachial index as a marker of cognitive impairment and dementia in general population: a systematic review. Atherosclerosis 216, 251-257 (2011).
95. Guerchet, M. et al. Association between a low ankle-brachial index and dementia in a general elderly population in Central Africa (Epidemiology of Dementia in Central Africa Study). J. Am. Geriatr. Soc. 61, 1135-1140 (2013).
96. Laukka, E. J., Starr, J. M. & Deary, I. J. Lower ankle-brachial index is related to worse cognitive performance in old age. Neuropsychology 28, 281-289 (2014).
97. Hofman, A. et al. Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study. Lancet 349, 151-154 (1997).
98. Arntzen, K. A. et al. Carotid atherosclerosis predicts lower cognitive test results: a 7-year follow-up study of 4, 371 stroke-free subjects-the Tromsø study. Cerebrovasc. Dis. 33, 159-165 (2012).
99. Zhong, W. et al. Carotid atherosclerosis and 10-year changes in cognitive function. Atherosclerosis 224, 506-510 (2012).
100. Romero, J. R. et al. Carotid artery atherosclerosis, MRI indices of brain ischemia, aging, and cognitive impairment: the Framingham study. Stroke 40, 1590-1596 (2009).
101. Chang, X. L. et al. Association between asymptomatic carotid stenosis and cognitive function: a systematic review. Neurosci. Biobehav. Rev. 37, 493-499 (2013).
102. Balestrini, S. et al. Severe carotid stenosis and impaired cerebral hemodynamics can influence cognitive deterioration. Neurology 80, 2145-2150 (2013).
103. Franklin, S. S. Beyond blood pressure: arterial stiffness as a new biomarker of cardiovascular disease. J. Am. Soc. Hypertens. 2, 140-151 (2008).
104. Poels, M. M. et al. Arterial stiffness, cognitive decline, and risk of dementia: the Rotterdam study. Stroke 38, 888-892 (2007).
105. Elias, M. F. et al. Arterial pulse wave velocity and cognition with advancing age. Hypertension 53, 668-673 (2009).
106. Tsao, C. W. et al. Relations of arterial stiffness and endothelial function to brain aging in the community. Neurology 81, 984-991 (2013).
107. Waldstein, S. R. et al. Pulse pressure and pulse wave velocity are related to cognitive decline in the Baltimore Longitudinal Study of Aging. Hypertension 51, 99-104 (2008).
108. Zeki Al Hazzouri, A. et al. Pulse wave velocity and cognitive decline in elders: the Health, Aging, and Body Composition study. Stroke 44, 388-393 (2013).
109. Watson, N. L. et al. Arterial stiffness and cognitive decline in well-functioning older adults. J. Gerontol. A. Biol. Sci. Med. Sci. 66, 1336-1342 (2011).
110. Singer, J. et al. Arterial stiffness, the brain and cognition: a systematic review. Ageing Res. Rev. 15, 16-27 (2014).
111. Elias-Smale, S. E. et al. Coronary calcium score improves classification of coronary heart disease risk in the elderly: the Rotterdam study. J. Am. Coll. Cardiol. 56, 1407-1414 (2010).
112. Rosano, C., Naydeck, B., Kuller, L. H., Longstreth, W. T. Jr. & Newman, A. B. Coronary artery calcium: associations with brain magnetic resonance imaging abnormalities and cognitive status. J. Am. Geriatr. Soc. 53, 609-615 (2005).
113. Vidal, J. S. et al. Coronary artery calcium, brain function and structure: the AGES-Reykjavik Study. Stroke 41, 891-897 (2010).
114. Bos, D. et al. Atherosclerotic calcification relates to cognitive function and to brain changes on magnetic resonance imaging. Alzheimers Dement. 8, S104-S111 (2012).
115. Dadu, R. T. et al. Cardiovascular biomarkers and subclinical brain disease in the atherosclerosis risk in communities study. Stroke 44, 1803-1808 (2013).
116. Schneider, A. L. et al. High-sensitivity cardiac troponin T and cognitive function and dementia risk: the atherosclerosis risk in communities study. Eur. Heart J. 35, 1817-1824 (2014).
117. Qiu, C. et al. Microvascular lesions in the brain and retina: The age, gene/environment susceptibility-Reykjavik study. Ann. Neurol. 65, 569-576 (2009).
118. McClintic, B. R., McClintic, J. I., Bisognano, J. D. & Block, R. C. The relationship between retinal microvascular abnormalities and coronary heart disease: a review. Am. J. Med. 123, 374.e1-374.e7 (2010).
119. Li, L. J., Lee, Y. S., Wong, T. Y. & Cheung, C. Y. Can the retinal microvasculature offer clues to cardiovascular risk factors in early life? Acta Paediatr. 102, 941-946 (2013).
120. Qiu, C. et al. Cerebral microbleeds, retinopathy, and dementia: the AGES-Reykjavik Study. Neurology 75, 2221-2228 (2010).
121. Ikram, M. K., Cheung, C. Y., Wong, T. Y. & Chen, C. P. Retinal pathology as biomarker for cognitive impairment and Alzheimer's disease. J. Neurol. Neurosurg. Psychiatry 83, 917-922 (2012).
122. Heringa, S. M. et al. Associations between retinal microvascular changes and dementia, cognitive functioning, and brain imaging abnormalities: a systematic review. J. Cereb. Blood Flow Metab. 33, 983-995 (2013).
123. Selnes, O. A. et al. Cognitive and neurologic outcomes after coronary-artery bypass surgery. N. Engl. J. Med. 366, 250-257 (2012).
124. Kennedy, E. D. et al. Cognitive outcome after on-and off-pump coronary artery bypass grafting surgery: a systematic review and meta-analysis. J. Cardiothorac. Vasc. Anesth. 27, 253-265 (2013).
125. Muqtadar, H., Testai, F. D. & Gorelick, P. B. The dementia of cardiac disease. Curr. Cardiol. Rep. 14, 732-740 (2012).
126. Schwarz, N. et al. Cognitive decline and ischemic microlesions after coronary catheterization. A comparison to coronary artery bypass grafting. Am. Heart J. 162, 756-763 (2011).
127. Gold, G. et al. Identification of Alzheimer and vascular lesion thresholds for mixed dementia. Brain 130, 2830-2836 (2007).
128. Boyle, P. A. et al. Much of late life cognitive decline is not due to common neurodegenerative pathologies. Ann. Neurol. 74, 478-489 (2013).
129. Kalaria, R. N. Cerebrovascular disease and mechanisms of cognitive impairment: evidence from clinicopathological studies in humans. Stroke 43, 2526-2534 (2012).
130. Pantoni, L. Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol. 9, 689-701 (2010).
131. Brundel, M., de Bresser, J., van Dillen, J. J., Kappelle, L. J. & Biessels, G. J. Cerebral microinfarcts: a systematic review of neuropathological studies. J. Cereb. Blood Flow Metab. 32, 425-436 (2012).
132. Lawrence, A. J., Chung, A. W., Morris, R. G., Markus, H. S. & Barrick, T. R. Structural network efficiency is associated with cognitive impairment in small-vessel disease. Neurology 83, 304-311 (2014).
133. Pase, M. P. Modifiable vascular markers for cognitive decline and dementia: the importance of arterial aging and hemodynamic factors. J. Alzheimers Dis. 32, 653-663 (2012).
134. Richardson, K. et al. The neuropathology of vascular disease in the Medical Research Council Cognitive Function and Ageing Study (MRC CFAS). Curr. Alzheimer Res. 9, 687-696 (2012).
135. Knopman, D. S. et al. Vascular risk factors and longitudinal changes on brain MRI: the ARIC study. Neurology 76, 1879-1885 (2011).
136. Shah, N. S. et al. Midlife blood pressure, plasma β-amyloid, and the risk for Alzheimer disease: the Honolulu Asia Aging Study. Hypertension 59, 780-786 (2012).
137. Rodrigue, K. M. et al. Risk factors for β-amyloid deposition in healthy aging: vascular and genetic effects. JAMA Neurol. 70, 600-606 (2013).
138. Qiu, C. et al. Diabetes, markers of brain pathology and cognitive function: the age, gene/environment susceptibility-Reykjavik Study. Ann. Neurol. 75, 138-146 (2014).
139. Cardenas, V. A. et al. Associations among vascular risk factors, carotid atherosclerosis, and cortical volume and thickness in older adults. Stroke 43, 2865-2870 (2012).
140. Reed, B. R. et al. Coronary risk correlates with cerebral amyloid deposition. Neurobiol. Aging 33, 1979-1987 (2012).
141. Villeneuve, S. et al. Vascular risk and Aβ interact to reduce cortical thickness in AD vulnerable brain regions. Neurology 83, 40-47 (2014).
142. Dublin, S. et al. Neuropathologic changes associated with atrial fibrillation in a population-based autopsy cohort. J. Gerontol. A. Biol. Sci. Med. Sci. 69, 609-615 (2014).
143. Attems, J. & Jellinger, K. A. The overlap between vascular disease and Alzheimer's disease-lessons from pathology. BMC Med. 12, 206 (2014).
144. Yarchoan, M. et al. Cerebrovascular atherosclerosis correlates with Alzheimer pathology in neurodegenerative dementias. Brain 135, 3749-3756 (2012).
145. Dolan, H. et al. Atherosclerosis, dementia, and Alzheimer disease in the Baltimore Longitudinal Study of Aging cohort. Ann. Neurol. 68, 231-240 (2010).
146. Zheng, L. et al. Cerebral atherosclerosis is associated with cystic infarcts and microinfarcts but not Alzheimer pathologic changes. Stroke 44, 2835-2841 (2013).
147. Casserly, I. & Topol, E. Convergence of atherosclerosis and Alzheimer's disease: inflammation, cholesterol, and misfolded proteins. Lancet 363, 1139-1146 (2004).
148. Strozyk, D. et al. Contribution of vascular pathology to the clinical expression of dementia. Neurobiol. Aging 31, 1710-1720 (2010).
149. Henskens, L. H. et al. Increased aortic pulse wave velocity is associated with silent cerebral small-vessel disease in hypertensive patients. Hypertension 52, 1120-1126 (2008).
150. Mitchell, G. F. et al. Arterial stiffness, pressure and flow pulsatility and brain structure and function: The age, gene/environment susceptibility-Reykjavik study. Brain 134, 3398-3407 (2011).
151. Hassell, M. E. et al. Silent cerebral infarcts associated with cardiac disease and procedures. Nat. Rev. Cardiol. 10, 696-706 (2013).
152. Chen, L. Y. et al. Atrial fibrillation and cognitive decline-the role of subclinical cerebral infarcts: the atherosclerosis risk in communities study. Stroke 45, 2568-2574 (2014).
153. Rahman, F., Kwan, G. F. & Benjamin, E. J. Global epidemiology of atrial fibrillation. Nat. Rev. Cardiol. 11, 639-654 (2014).
154. Whalley, L. J., Dick, F. D. & McNeill, G. A life-course approach to the aetiology of late-onset dementias. Lancet Neurol. 5, 87-96 (2006).
155. DeCarli, C. Assessing the brain as an end-organ of vascular disease. Nat. Rev. Cardiol. 9, 435-436 (2012).
156. Goldenberg, I. et al. Cumulative burden of atherosclerotic risk genotypes and the age at onset of a first myocardial infarction: a case-only carriership approach. Ann. Noninvasive Electrocardiol. 13, 287-294 (2008).
157. Shiue, I. Age of onset for stroke delayed in the 21st century: what is next? Clin. Neurol. Neurosurg. 113, 725-726 (2011).
158. Matthews, F., Brayne, C. & Medical Research Council Cognitive Function and Ageing Study Investigators. The incidence of dementia in England and Wales: findings from the five identical sites of the MRC CFA Study. PLoS Med. 2, e193 (2005).
159. Tzourio, C. et al. Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease. Arch. Intern. Med. 163, 1069-1075 (2003).
160. Willis, K. J. & Hakim, A. M. Stroke prevention and cognitive reserve: emerging approaches to modifying risk and delaying onset of dementia. Front. Neurol. 4, 13 (2013).
161. Mearns, B. M. & Fuster, V. Highlight dementia risk to reduce CVD. Nat. Rev. Cardiol. 7, 237 (2010).
162. Brookmeyer, R., Johnson, E., Ziegler-Graham, K. & Arrighi, H. M. Forecasting the global burden of Alzheimer's disease. Alzheimers Dement. 3, 186-191 (2007).
163. Solomon, A. et al. Advances in the prevention of Alzheimer's disease and dementia. J. Intern. Med. 275, 229-250 (2014).
164. Rocca, W. A. et al. Trends in the incidence and prevalence of Alzheimer's disease, dementia, and cognitive impairment in the United States. Alzheimers Dement. 7, 80-93 (2011).
165. Wiberg, P., Waern, M., Billstedt, E., Ostling, S. & Skoog, I. Secular trends in the prevalence of dementia and depression in Swedish septuagenarians 1976-2006. Psychol. Med. 43, 2627-2634 (2013).
166. Matthews, F. E. et al. A two-decade comparison of prevalence of dementia in individuals aged 65 years and older from three geographical areas of England: results of the Cognitive Function and Ageing Study I and II. Lancet 382, 1405-1412 (2013).
167. Schrijvers, E. M. et al. Is dementia incidence declining? Trends in dementia incidence since 1990 in the Rotterdam Study. Neurology 78, 1456-1463 (2012).
168. Qiu, C., von Strauss, E., Bäckman, L., Winblad, B. & Fratiglioni, L. Twenty-year changes in dementia occurrence suggest decreasing incidence in central Stockholm, Sweden. Neurology 80, 1888-1894 (2013).
169. Jones, D. S. & Greene, J. A. The decline and rise of coronary heart disease: understanding public health catastrophism. Am. J. Public. Health. 103, 1207-1218 (2013).
170. Chan, K. Y. et al. Epidemiology of Alzheimer's disease and other forms of dementia in China, 1990-2010: a systematic review and analysis. Lancet 381, 2016-2023 (2013).
171. Yang, G. et al. Rapid health transition in China, 1990-2010: findings from the Global Burden of Disease Study 2010. Lancet 381, 1987-2015 (2010).
172. Liang, Y., Liu, R., Du, S. & Qiu, C. Trends in incidence of hypertension in Chinese adults, 1991-2009: The China Health and Nutrition Survey. Int. J. Cardiol. 175, 96-101 (2014).